Michael Groher, Ph.D., F-ASHA, Author at Dysphagia Cafe

1 POSTS 0 COMMENTS

Michael Groher is a professor and chair of the Department of Communicative Disorders at the University of Redlands in Redlands, California. Dr. Groher has spent most of his career working as a medical speech pathologist in acute and long-term care settings. The majority of hospital work was done for the Department of Veterans Affairs in Seattle/Tacoma, New York, and Tampa. He is best known for his pioneering work with patients who have swallowing disorders. The majority of his work is summarized in three texts: Dysphagia: Diagnosis and Management (Three editions), Introduction to Adult Swallowing Disorders, and Clinical Management of Dysphagia in Adults and Children, second edition in press. Dr. Groher is an ASHA Fellow, has received Honors from ASHA, and is a past founding associate editor for the journal Dysphagia. He is an honorary member of the Japanese Society of Dysphagia Rehabilitation.

The Historical role of the SLP in dysphagia management

Michael Groher, Ph.D., F-ASHA - August 31, 2016

Scroll for Important Safety Information

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.